Jove
Visualize
Contact Us

Related Experiment Videos

Diagnosing collagenous colitis: does it make a difference?

W J Tremaine1

  • 1Inflammatory Bowel Disease Clinic, Division of Gastroenterology, Mayo Clinic, Rochester, Minnesota 55905, USA. tremaine.william@mayo.edu

European Journal of Gastroenterology & Hepatology
|February 7, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Letter: the definition of budesonide dependence in microscopic colitis-authors' reply.

Alimentary pharmacology & therapeutics·2017
Same author

Immune modulator therapy for microscopic colitis in a case series of 73 patients.

Alimentary pharmacology & therapeutics·2017
Same author

Efficacy and safety of certolizumab pegol for Crohn's disease in clinical practice.

Alimentary pharmacology & therapeutics·2015
Same author

Idiopathic inflammatory demyelinating disease of the central nervous system in patients with inflammatory bowel disease: retrospective analysis of 9095 patients.

Alimentary pharmacology & therapeutics·2014
Same author

Letter: Effectiveness of split-dose certolizumab pegol for Crohn's disease.

Alimentary pharmacology & therapeutics·2013
Same author

Issues in the development of practice guidelines for inflammatory bowel disease.

Inflammatory bowel diseases·2013
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Collagenous colitis, a microscopic colitis, stems from fecal stream toxins causing mucosal injury. Diagnosis relies on colon pathology and clinical signs, with varied treatments available.

Area of Science:

  • Gastroenterology
  • Colorectal Pathology
  • Inflammatory Bowel Disease

Background:

  • Collagenous colitis is a subtype of microscopic colitis.
  • It is characterized by a thickened subepithelial collagen band.
  • This condition is linked to mucosal injury from fecal toxins.

Purpose of the Study:

  • To define collagenous colitis within the spectrum of microscopic colitis.
  • To elucidate the pathophysiology of collagenous colitis.
  • To outline diagnostic criteria and treatment options.

Main Methods:

  • Diagnosis is based on colonic mucosal biopsy findings.
  • Histopathological examination reveals a characteristic collagen band.
  • Clinical presentation is also considered for diagnosis.

Related Experiment Videos

Main Results:

  • The collagen band is a consequence of inflammation, not the primary cause of symptoms.
  • Collagenous colitis is associated with fecal stream-induced mucosal damage.
  • Other microscopic colitis types include lymphocytic colitis and mixed disorders.

Conclusions:

  • Collagenous colitis is an inflammatory condition resulting from mucosal injury.
  • Diagnosis requires correlating colonic pathology with clinical presentation.
  • Treatment approaches are empirical, ranging from conservative management to surgical intervention.